Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
US |
|
Cronos Group Inc
TSX:CRON
|
CA |
|
T
|
Tiger Brands Ltd
JSE:TBS
|
ZA |
|
First Quantum Minerals Ltd
TSX:FM
|
CA |
|
One Media IP Group PLC
LSE:OMIP
|
UK |
|
A
|
Averbuch Formica Center Ltd
TASE:AVER
|
IL |
|
M
|
Marel hf
ICEX:MAREL
|
IS |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
Sunopta Inc
TSX:SOY
|
CA |
|
P
|
Pico Thailand PCL
SET:PICO
|
TH |
|
S
|
Silla Co Ltd
KRX:004970
|
KR |
Wall Street
Price Targets
SNOA Price Targets Summary
Sonoma Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
SNOA
is 15.1 USD
with a low forecast of 14.95 USD and a high forecast of 15.54 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SNOA's stock price target?
Price Target
15.1
USD
According to Wall Street analysts, the average 1-year price target for
SNOA
is 15.1 USD
with a low forecast of 14.95 USD and a high forecast of 15.54 USD.
What is Sonoma Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
24%
For the last 13 years the
compound annual growth rate for
Sonoma Pharmaceuticals Inc's revenue is
1%.
The projected
CAGR
for the next 3 years is
24%.
